Target Name: GBE1
NCBI ID: G2632
Review Report on GBE1 Target / Biomarker Content of Review Report on GBE1 Target / Biomarker
GBE1
Other Name(s): glucan (1,4-alpha-), branching enzyme 1 | 1,4-alpha-glucan-branching enzyme | OTTHUMP00000213833 | Alpha-glucan-branching glycosyltransferase | Amylose isomerase | Branching enzyme | amylo-(1,4 to 1,6) transglucosidase | 1,4-alpha-glucan branching enzyme 1 | Amylo-(1,4 to 1,6) transglycosylase | GSD4 | Enzyme Q | Q-enzyme | Amylo-(1,4 to 1,6) transglucosidase | Amylo-(1,4->1,6)-transglycosylase | Branching glycosyltransferase | Glycogen-branching enzyme | amylo-(1,4 to 1,6) transglycosylase | GLGB_HUMAN | brancher enzyme | Brancher enzyme | GBE | OTTHUMP00000213788 | 1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-alpha-D-(1,4-alpha-D-glucano)-transferase | glycogen branching enzyme | Glucan (1,4-alpha-), branching enzyme 1 | Glucosan transglycosylase | Enzymatic branching factor | Plant branching enzyme | APBD | Glycogen branching enzyme | Alpha-1,4-glucan:alpha-1,4-glucan-6-glycosyltransferase | Starch branching enzyme

GBE1: A Glucan Enzyme Involved in Glucose Metabolism and Cellular Signaling

GBE1 (Glucan (1,4-alpha-), branching enzyme 1) is a protein that is expressed in various cell types, including tissues, organs, and organs. It is a member of the GBE family of enzymes, which are involved in the branching of glucose. GBE1 is primarily localized to the endoplasmic reticulum (ER) and is involved in the degradation of glucose.

GBE1 is a critical enzyme in the regulation of glucose metabolism. It catalyzes the conversion of glucose-6-phosphate (G6P) to glucose-6-carboxylate (G6C). This reaction is a key step in the branching pathway of glucose metabolism, which is involved in the production of glucose from simple sugars.

GBE1 is also involved in the regulation of cellular signaling pathways. It has been shown to be involved in the regulation of cell adhesion, cell signaling, and cellular growth. GBE1 has been shown to play a role in the regulation of T-cell development and in the regulation of inflammation.

GBE1 is a potential drug target for the treatment of various diseases. It is involved in the regulation of glucose metabolism, which is a crucial aspect of cellular metabolism and has been implicated in the development and progression of many diseases. GBE1 is also involved in the regulation of cellular signaling pathways, which has been implicated in the development of various diseases.

GBE1 is a potential biomarker for the diagnosis and monitoring of various diseases. Its expression has been shown to be affected by a variety of conditions, including diabetes, cancer, and infection. GBE1 has also been shown to be involved in the regulation of cellular signaling pathways, which can be used as a potential biomarker for the diagnosis and monitoring of various diseases.

In conclusion, GBE1 (Glucan (1,4-alpha-), branching enzyme 1) is a protein that is involved in the regulation of glucose metabolism and cellular signaling pathways. It is a potential drug target and biomarker for the treatment of various diseases. Further research is needed to fully understand the role of GBE1 in glucose metabolism and its potential as a drug target and biomarker.

Protein Name: 1,4-alpha-glucan Branching Enzyme 1

Functions: Required for normal glycogen accumulation (PubMed:8463281, PubMed:26199317, PubMed:8613547). The alpha 1-6 branches of glycogen play an important role in increasing the solubility of the molecule (Probable)

The "GBE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GBE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH | GCFC2 | GCG | GCGR | GCH1 | GCHFR | GCK | GCKR | GCLC | GCLM | GCM1 | GCM2 | GCN1 | GCNA | GCNT1 | GCNT1P3 | GCNT2 | GCNT3 | GCNT4 | GCNT7 | GCOM1 | GCSAM | GCSAML | GCSAML-AS1 | GCSH | GCSHP3 | GCSIR | GDA | GDAP1 | GDAP1L1 | GDAP2 | GDE1 | GDF1 | GDF10 | GDF11 | GDF15 | GDF2 | GDF3 | GDF5 | GDF6 | GDF7 | GDF9 | GDI1 | GDI2 | GDI2P1 | GDNF | GDNF Family Receptor alpha | GDNF-AS1 | GDPD1 | GDPD2 | GDPD3 | GDPD4 | GDPD5 | GDPGP1 | GEM | GEMIN2 | GEMIN4 | GEMIN5 | GEMIN6 | GEMIN7 | GEMIN8 | GEMIN8P1 | GEMIN8P4 | GEN1 | general transcription factor IIF (TFIIF) | General transcription factor IIH | Geranylgeranyl transferase | Geranylgeranyl transferase type-1 | GET1 | GET3 | GET4 | GFAP | GFER | GFI1 | GFI1B | GFM1 | GFM2 | GFOD1 | GFOD2 | GFPT1 | GFPT2 | GFRA1